The Effect of Hepcidin on Cardiac Ischemia-Reperfusion Injury

References

• Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/reperfusion. Compr Physiol. 2016;7(1):113–170.
   PubMed Web of Science ®Google Scholar
• Teagtmeyer H, King LM, Jones BE. Energy substrate metabolism, myocardial ischemia, and targets of pharmacotherapy. Am J Cardiol. 1998; 82:54–60.
   PubMed Web of Science ®Google Scholar
• Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther. 2001;89(1):29–46.
   PubMed Web of Science ®Google Scholar
• Damjanov I, Linder J. Cell injury and cellular adaptations. In: Anderson’s Pathology. 10th ed. St. Louis: Mosby; 1996:357–365.
   Google Scholar
• Piper HM, Meuter K, Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg. 2003; 75:644–648.
   PubMed Web of Science ®Google Scholar
• Verma S, Fedak PW, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 20:2332–2336. doi: 10.1161/01.CIR.0000016602.96363.36.
   Web of Science ®Google Scholar
• Angmo S, Tripathi N, Abbat S, et al. Identification of guanosine 5'-diphosphate as potential iron mobilizer: preventing the hepcidin-ferroportin interaction and modulating the interleukin-6/Stat-3 Pathway. Sci Rep. 2017; 7:40097.
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Darshan D, Wilkins SJ, Frazer DM. Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals 2007;20(3–4):665–674.
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 2005;18(2):171–182.
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology 2006; 507:29–35. doi: 10.1182/asheducation-2006.1.29.
   Google Scholar
• Loncar R, Flesche CW, Deussen A. Myocardial ferritin content is closely related to the degree of ischaemia. Acta Physiol Scand. 2004;180(1):21–28.
   PubMedGoogle Scholar
• Voogd A, Sluiter W, van Eijk HG, Koster JF. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest. 1992;90(5):2050–2055.
   PubMed Web of Science ®Google Scholar
• Muñoz Gómez M, Campos Garríguez A, García Erce JA, Ramírez Ramírez G. Physiopathology of iron metabolism: diagnostic and therapeutic implications. Nefrologia 2005; 25:9–19.
   PubMedGoogle Scholar
• Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99(10):3505–3516.
   PubMed Web of Science ®Google Scholar
• Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 2007;148(6):2663–2668.
   PubMed Web of Science ®Google Scholar
• Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. NitricOxide 2001;51:62–71. doi: 10.1006/niox.2000.0319.
   Google Scholar
• Casini AF, Ferrali M, Pompella A, Maellaro E, Comporti M. Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene-intoxicated mice. Am J Pathol. 1986;123(3):520–531.
   PubMed Web of Science ®Google Scholar
• Aykaç G, Uysal M, Yalçin AS, Koçak-Toker N, Sivas A, Oz H. The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology 1985;36(1):71–76.
   PubMed Web of Science ®Google Scholar
• Kali A, Charles MV, Seetharam RS. Hepcidin - a novel biomarker with changing trends. Pharmacogn Rev. 2015;9(17):35–40.
   PubMedGoogle Scholar
• Esmaeili H, Hafezimoghadam Z, Esmailidehaj M, Rezvani ME, Hafizibarjin Z. The effect of asafoetida essential oil on myocardial ischemic-reperfusion injury in isolated rat hearts. Avicenna J Phytomed. 2018; 8(4):338–349.
   PubMed Web of Science ®Google Scholar
• Oz E, Arsakay G, Dinçer S, Erbaş D. Role of the nitric oxide pathway on ischemia-reperfusion injury in an isolated perfused guinea pig heart. Gen Pharmacol. 2000;34(1):3–7. Jandoi: 10.1016/S0306-3623(99)00044-0.
   PubMedGoogle Scholar
• Gonon AT, Erbas D, Bröijersén A, Valen G, Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2004;286(5):H1767–H1774.
   PubMed Web of Science ®Google Scholar
• Simonis G, Mueller K, Schwarz P, et al. The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 2010; 9:1786–1790. doi: 10.1016/j.peptides.2010.05.013.
   Web of Science ®Google Scholar
• Isoda M, Hanawa H, Watanabe R, et al. Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction. J Nutr Biochem. 2010; 8:749–756. doi: 10.1016/j.jnutbio.2009.04.009.
   Web of Science ®Google Scholar
• Beckman JS. -OONO: rebounding from nitric oxide. Circ Res. 2001;89(4):295–297.
   PubMed Web of Science ®Google Scholar
• Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning. Br J Pharmacol. 2003;138(4):532–543. doi: 10.1038/sj.bjp.0705080.
   PubMed Web of Science ®Google Scholar
• Ronson RS, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 1999;44(1):47–59.
   PubMed Web of Science ®Google Scholar
• Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA.1996;93(26):15069–15074. doi: 10.1073/pnas.93.26.15069.
   PubMed Web of Science ®Google Scholar
• Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288(2):481–487. doi: 10.1016/0003-9861(91)90224-7.
   PubMed Web of Science ®Google Scholar
• Wildhirt SM, Weismueller S, Schulze C, Conrad N. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to disorders to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res.1999;43(3):698–711. doi: 10.1016/S0008-6363(99)00080-2.
   PubMed Web of Science ®Google Scholar
• James JP, Benedict RL. Mechanism of myocardial reperfusion injury. Ann Thorac Surg 1999; 68:1905–1912.
   PubMed Web of Science ®Google Scholar
• Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg. 1999;68(5):1898–1904.
   PubMed Web of Science ®Google Scholar
• Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion injury, a clinical view on a complex pathophysiological process. Int J Cardiol.2005;100(2):179–190. doi: 10.1016/j.ijcard.2004.04.013.
   PubMed Web of Science ®Google Scholar
• Kandilci HB, Gümüşel B. Akciğerlerde iskemi-reperfüzyon hasari ve iskemik önkoşullama. Hacettepe Üniversitesi, Eczacılık Fakültesi Dergisi 2005; 1:35–49.
   Google Scholar
• Benkoel L, Dodero F, Hardwigsen J, et al. Effect of ischemia-reperfusion on Na+, K+-ATPase expression in human liver tissue allograft: image analysis by confocal laser scanning microscopy. Dig Dis Sci. 2004;49(9):1387–1393. doi: 10.1023/B:DDAS.0000042235.72622.16.
   PubMed Web of Science ®Google Scholar
• White BC, Grossman LI, Krause GS. Brain injury by global ischemia and reperfusion: a theoretical perspective on membrane damage and repair. Neurology 1993;43(9):1656–1665.
   PubMed Web of Science ®Google Scholar
• Liu JX, Tanonaka K, Ohtsuka Y, Sakai Y, Takeo S. Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents. J Pharmacol Exp Ther. 1993;266(3):1247–1254.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu Y. Effect of hepcidin on proliferation, apoptosis, mineralization and gene expression of osteoblast (hFOB1.19) in vitro. Bone 2010; 47:S407. doi: 10.1016/j.bone.2010.09.198.
   Web of Science ®Google Scholar
• Sasai M, Iso Y, Mizukami T, et al. Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human. Int J Cardiol. 2017;227:114–121.
   PubMed Web of Science ®Google Scholar
• Scindia Y, Dey P, Thirunagari A, et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol. 2015;26(11):2800–2814. Novdoi: 10.1681/ASN.2014101037.
   PubMed Web of Science ®Google Scholar
• Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255–266.
   PubMed Web of Science ®Google Scholar
• Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001;94(6):1133–1138.
   PubMed Web of Science ®Google Scholar